North America Active Implantable Medical Devices Market Size, Share & Trends Analysis Report By Product Type (Implantable Cardioverter Defibrillators, Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators, Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Active Hearing Implants, Non-active/Passive Hearing Implants), By End-User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

North America Active Implantable Medical Devices Market Size

The North America active Implantable Medical Devices Market size was valued at USD 9.98 billion in 2025 and is projected to grow from USD 10.69 billion in 2026 to reach USD 18.50 billion by 2034, growing at a CAGR of 7.1% during the forecast period 2026–2034.

Technological advancements in AIMDs, the rising prevalence of chronic diseases, and the presence of a robust healthcare infrastructure drive the region's market. Furthermore, the increasing demand for advanced cardiac care devices and neuromodulation systems also supports the growth of this market.

Product Insights

Implantable Cardioverter Defibrillators dominate the product segment and is expected to grow at a CAGR of 7.2% over the forecast period. These devices are integral in preventing sudden cardiac deaths, especially among patients with arrhythmias. The development of subcutaneous ICDs (S-ICDs) further enhances adoption, offering a less invasive alternative to traditional ICDs. Key manufacturers like Medtronic and Boston Scientific are driving innovation in this segment.

Request Customizationto receive a tailored report.

End User Insights

Hospitals dominates the end-user segment and is expected to grow at a CAGR of 6.6% during the forecast period. Hospitals remain the primary point of care for AIMD implantation due to their advanced infrastructure and skilled personnel. Increasing investments in robotic-assisted surgeries further bolster this segment.

Speak to an Analystto discuss market opportunities.

North America Active Implantable Medical Devices Market Regional Insights

The market is characterized by a strong healthcare infrastructure, high disposable income, and early adoption of advanced medical technologies. The growth trajectory varies across countries based on healthcare spending, disease prevalence, and regulatory frameworks.

• The U.S. accounts for the largest share of the North American AIMDs market. The CDC reported in 2024 that nearly 6 million Americans suffer from heart failure, driving demand for pacemakers and ICDs. Companies like Abbott Laboratories and Boston Scientific lead the market with innovations such as Bluetooth-enabled pacemakers. The U.S. government's focus on expanding healthcare access through programs like Medicare Advantage further supports growth.
• Canada's AIMDs market is driven by its universal healthcare system, which covers a significant portion of device implantation costs. The rise in neurological disorders, reported by the Canadian Neurological Sciences Federation (CNSF), has spurred demand for neurostimulators. Additionally, government grants for medical research and device development support the market's expansion.
• Mexico is emerging as a growing market, driven by increasing healthcare awareness and medical tourism. Affordable procedures attract international patients, particularly for cardiac implants. The Mexican Ministry of Health reported a 12% annual increase in pacemaker implantation in 2024.
• Puerto Rico, with its growing healthcare infrastructure and access to advanced medical devices, contributes to regional growth. Investments in healthcare facilities and research by multinational companies strengthen its market position.
• Cuba's healthcare system emphasizes preventive care, but collaborations with foreign manufacturers have introduced AIMDs to manage severe cases. Ongoing partnerships between Cuban health authorities and global players like Medtronic are expected to boost growth.

List of Key and Emerging Players in North America Active Implantable Medical Devices Market